Samsung Bioepis Announces US Launch of ONTRUZANT for Early and Metastatic HER2-overexpressing Breast Cancer and Metastatic Gastric Cancer

▴ Samsung Bioepis Announces US Launch of ONTRUZANT for Early and Metastatic HER2 overexpressing Breast Cancer and Metastatic Gastric Cancer
ONTRUZANT is Samsung Bioepis’ first oncology biosimilar available in the United States

Samsung Bioepis Co., Ltd. announced today that ONTRUZANT (trastuzumab-dttb), a biosimilar of the reference biologic medicine HERCEPTI(trastuzumab) for the treatment of HER2-overexpressing breast cancer, metastatic breast cancer, and metastatic gastric cancer or gastroesophageal junction adenocarcinoma, is now available in the United States. Patients should be selected for therapy based on an FDA-approved companion diagnostic for a trastuzumab product. ONTRUZANT is available in both 150 mg single-dose vials and 420 mg multi-dose vials. Please see Boxed Warnings and Important Safety Information for ONTRUZANT below.


The launch follows the approval from the US FDA in January 2019 for the 150 mg vial and in March 2020 for the 420 mg vial, based on Samsung Bioepis’ comprehensive data package, including analytical, nonclinical and clinical pharmacokinetic, safety and effectiveness data demonstrating that ONTRUZANT is highly similar to its reference product HERCEPTIN®, and there are no clinically meaningful differences in terms of the safety, purity and potency of the product.i,ii,iii,iv,v,vi


“The launch of ONTRUZANT® to deliver our first oncology biosimilar in the US marks an important milestone for Samsung Bioepis, and more importantly, for the patients who are in need of this proven treatment,” said Christopher Ko, President and Chief Executive Officer, Samsung Bioepis. He continued, “While we understand that this is an unprecedented time for our hospitals and healthcare workers, we at Samsung Bioepis remain steadfastly committed to the patients we serve through our efforts to ensure the continued supply of our medicines through collaboration with our manufacturing and commercial partners.”

ONTRUZANT will be marketed and distributed in the US by Merck (known as MSD outside the US and Canada), which announced on February 5, 2020, that it intends to spin-off certain products, amongst them ONTRUZANT® and its biosimilars businesses, into a new, independent, publicly-traded company. Merck will continue to fully support the commercialization of ONTRUZANT until the spinoff, which is intended to take place in the first half of 2021, at which time ONTRUZANT will become a product of the new company.


Under terms of agreement, Samsung Bioepis is responsible for preclinical and clinical development, process development and manufacturing, clinical trials and regulatory registration while Merck is responsible for commercialization activities for products approved in its partnered territories, including the US.

Tags : #Samsung #Biopis #Ontruzant #Biosimilar #USA #Market

About the Author


Team Medicircle

Related Stories

07 Sep

JNCASR researchers develop diagnostic therapy for Lung Cancer

Now a safe and cheap way for determining lungs cancer

View
29 Aug

Citriodiol in insect repellent may protect against COVID-19: UK study

Citriodiol had anti-viral properties if mixed with the virus in the liquid phase and on a test surface

View
05 Aug

INST develops new kit to detect fluoride in drinking water

Equipment-free, a simple paper-strip based naked-eye fluoride ion detection and quantification kit in drinking water to evade Fluorosis-based disorders

View
29 Jul

SNBNCBS develops a device for screening of bilirubin level in new born

The operation of the device is based on non-contact and non-invasive spectrometry-based techniques for measurement of neonatal bilirubin level

View
17 Jul

ARCI & Vehant Technologies co-develop UV System for baggage

ARCI & Vehant Technologies co-develop UV System for baggage Scan Disinfection to fight COVID 19

View
15 Jul

Atal Innovation Mission to support Startups with COVID-19 Solutions

9 startups were chosen in the first round for funding

View
26 May

Molecular shock absorbers buffer axonal tension of nerve cells : RRI

Department of Science &Technology along with IISER Pune have proved Spectrin act as ‘shock absorbers’

View
14 May

DST initiatives to protect Divyangjan and Elderly

PSG College of Technology

View
13 Apr

IUSSTF boosts Indo-US virtual networks to address COVID 19 challenges

Collaboration across nations and organizations can leverage and share expertise across S&T communities and facilitate the development of a diverse, globally-engaged science, engineering, and technology-abled workforce, which can proactively work towards solutions for the Pandemic

View
07 Apr

Chandigarh University Uses 3D Printing Technology to Design Splitters That can Bridge Ventilators Shortfall in India

Chandigarh University had constituted a Core Research Group on the call made by Department of Science and Technology (DST) which had invited proposals from companies

View

-Advertisements-




Trending Now

Will India’s Healthcare Budget Support a Future of Robotic Surgeries?February 22, 2025
Is the World on the Brink of Another Pandemic? Scientists Discover a New Bat VirusFebruary 22, 2025
Newcastle University Expands Academic and Research Collaborations in IndiaFebruary 21, 2025
Get Ready to #BibaUp! Kriti Sanon Unveils the Season’s Most Stylish Summer CollectionFebruary 21, 2025
A Rare Condition: Surgery Saves 2-Day-Old Baby as Organs Shift Into ChestFebruary 21, 2025
Odisha’s Bold Healthcare Vision: A Rs 12,000 Crore Blueprint for Universal Health AccessFebruary 21, 2025
Young India’s Health Crisis: Why Insurance Claims Are Rising Among 25-35 Year OldsFebruary 21, 2025
India vs. Trump’s Pharma Tariff: The Battle Over Affordable MedicineFebruary 21, 2025
Foreign Medical Aspirants in Trouble: NMC’s Warning on Pending Eligibility CertificatesFebruary 21, 2025
Think Your Work Music Helps You Focus? Science Says Think AgainFebruary 21, 2025
Is Your Home’s Air Poisoning You? Shocking New Study Reveals Hidden Indoor Pollution RisksFebruary 20, 2025
The Society of Automotive Engineers & B V Raju Institution of Technology; to host the globally prestigious E-BAJA 2025; at Hyderabad!February 20, 2025
Eat right for your heart to beat rightFebruary 19, 2025
Aakash Healthcare and Medtronic Inaugurate North India’s First Dedicated Vein ClinicFebruary 19, 2025
Urgent and accelerated HIV service delivery with equity and rights is critical to end AIDSFebruary 19, 2025
Fasting Fad or Future Health Threat? Why Teens Should Think Twice Before Intermittent Fasting February 19, 2025
Public Hospitals Go High-Tech: AIIMS Delhi Leads India’s Robotic Surgery WaveFebruary 19, 2025
Screen Time and Healthy Habits: Navigating Optimal Development in ChildrenFebruary 18, 2025
SRM Global Hospitals Launches WOW, a Centre Exclusively for Women’s Health and WellnessFebruary 18, 2025
The Hidden Dangers of Scented Candles: Aesthetic Bliss or Silent Health Hazard?February 18, 2025